John Wiley & Sons Inc. posted fiscal first‑quarter 2027 results that fell short of Wall Street forecasts, yet its shares climbed 4.02% to $53.10 after the release. Adjusted earnings per share came in at $0.44 versus the consensus $0.46, while revenue reached $386 million, below the $404.8 million estimate. GAAP EPS recorded a loss of $0.23, reversing a $0.22 profit a year earlier.
Total revenue declined 3% year‑over‑year, but the research segment showed resilience, generating $293 million—a 4% increase—and delivering adjusted EBITDA of $87 million, up 9% with a margin that expanded 130 basis points to 29.6%. The segment’s growth was driven by a 12% rise in research publishing, partly attributed to the recent Emerald acquisition, which added $13 million of revenue. Excluding Emerald, organic research publishing grew about 5‑6%, outpacing the market’s 3‑4% estimate.
The learning segment weakened sharply, with revenue falling 19% to $93 million and adjusted EBITDA dropping 55% to $14 million. Margins compressed from 27.4% to 15.1% as both academic and professional sub‑segments fell 20%.
Artificial‑intelligence initiatives gained traction. Q1 AI‑related revenue hit $14 million, representing 28% of the full‑year target of over $50 million, and an additional $14 million was already contracted for the second and third quarters. Wiley now serves 23 corporate customers with subscription knowledge feeds across five industry verticals, six customers for model‑training partnerships, and 71 publisher partners for its Nexus licensing service. According to internal data, 84% of researchers use AI tools, and 73% seek guidance from publishers on AI application.
The company completed the Emerald acquisition at an approximate net cost of $450 million, valuing the deal at about 7x adjusted EBITDA. The transaction expands Wiley’s journal portfolio to roughly 2,500 titles, with 1,600 journals migrated to a new publishing platform, and is expected to be accretive to adjusted EPS by $0.10 in the first year. Cost synergies of $30 million are projected to be fully realized by year three.
Leverage remains elevated, with net debt‑to‑EBITDA at 2.7x on a trailing basis, improving to 2.1x pro forma after accounting for Emerald synergies, against a target range of 1.5‑2.5x. Free cash flow turned positive at $70 million for the quarter, compared with $100 million a year earlier, and the company returned $33 million to shareholders through dividends and share repurchases, marking the 33rd consecutive year of dividend increases.
For the full fiscal year 2027, Wiley reaffirmed guidance for organic revenue growth in the low to mid‑single‑digit range, adjusted EBITDA margin of 26.5%‑27.5%, adjusted EPS of $4.60‑$5.05, and free cash flow of $205 million.
CEO Matt Kissner emphasized the importance of accurate data for AI‑driven scientific research, while CFO Craig Albright highlighted disciplined capital allocation to enhance return on invested capital.
